Related Experiment Videos
Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brain
1Department of Pharmacology, Okayama University Medical School, Japan.
Abstract:
We examined the effects of MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger and an inhibitor of ischemia-induced brain edema, on monoamine metabolism in the brains of both normal and ischemic rats. In normal rats, 3 mg/kg i.v. MCI-186, a dose that prevents ischemic brain edema, had no significant effect on brain concentrations of dopamine, norepinephrine, 5-hydroxytryptamine, or their metabolites. After the injection of 5 microliters of 3% polyvinyl acetate into the left internal carotid artery, concentrations of 3,4-dihydroxyphenylacetic acid and homovanillic acid markedly increased, but that of norepinephrine decreased, in the left telencephalon of embolized rats compared with control rats injected with vehicle; the concentration of 5-hydroxyindoleacetic acid also increased slightly. These effects were maximal 2 hours after embolization. The turnover rate of dopamine between 6 and 8 hours after embolization was significantly higher but that of norepinephrine was slightly lower than that in vehicle-treated rats. When rats were treated with 3 mg/kg i.v. MCI-186 immediately after the injection of polyvinyl acetate, the embolization-induced changes in monoamine metabolism were less marked. Our results suggest that MCI-186 attenuates ischemia-induced changes in brain monoamine metabolism, probably due to its free radical scavenging action, although it has no marked effect in normal rats.
Insights
MCI-186, a free radical scavenger, reduces ischemia-induced changes in brain monoamine metabolism in rats. This neuroprotective agent does not affect normal rat brains but mitigates altered dopamine and norepinephrine levels during ischemia.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Ischemia-induced brain edema is a significant concern.
- Monoamine neurotransmitters play crucial roles in brain function.
- Free radical scavengers are investigated for neuroprotective properties.
Purpose of the Study:
- To investigate the effects of MCI-186 on monoamine metabolism in normal and ischemic rat brains.
- To determine if MCI-186's neuroprotective effects are linked to alterations in neurotransmitter levels.
- To assess MCI-186's efficacy in mitigating ischemia-induced changes in brain monoamine metabolism.
Main Methods:
- Rats were subjected to cerebral ischemia via internal carotid artery embolization.
- Monoamine concentrations and metabolite levels (dopamine, norepinephrine, serotonin) were measured.
- MCI-186 was administered intravenously before or after ischemia induction.
- Neurotransmitter turnover rates were calculated.
Main Results:
- MCI-186 did not significantly alter monoamine metabolism in normal rats.
- Ischemia led to increased dopamine and serotonin metabolites and decreased norepinephrine in the affected brain region.
- MCI-186 treatment attenuated these ischemia-induced changes in monoamine metabolism.
- Dopamine turnover was elevated post-ischemia, an effect reduced by MCI-186.
Conclusions:
- MCI-186 attenuates ischemia-induced alterations in brain monoamine metabolism.
- The free radical scavenging action of MCI-186 likely contributes to its neuroprotective effects.
- MCI-186 demonstrates potential as a therapeutic agent for ischemic brain injury by modulating neurotransmitter systems.